tiprankstipranks
Tenax Therapeutics Appoints Interim CFO Thomas McGauley
Company Announcements

Tenax Therapeutics Appoints Interim CFO Thomas McGauley

Pick the best stocks and maximize your portfolio:

Tenax Therapeutics ( (TENX) ) just unveiled an announcement.

Tenax Therapeutics, Inc. has appointed Thomas A. McGauley as Interim Chief Financial Officer, effective December 2, 2024. With over 25 years of experience in finance and executive roles, McGauley will lead the company’s financial operations under a consulting agreement with Danforth Advisors. His extensive background includes advisory roles at CBIZ and serving as CFO for various life sciences firms, making him well-suited to guide Tenax’s financial strategy.

See more insights into TENX stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyTenax Therapeutics reports Q3 EPS (19c) , consensus ($1.39)
TheFlyTenax Therapeutics reports Q3 EPS 19c, consensus ($1.39)
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App